XML 20 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY INVESTMENT - USD ($)
$ in Thousands
Total
Common Stock [Member]
Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Balance-beginning of period at Jan. 31, 2015 $ 324,781 $ 385 $ 162,675 $ 566,055 $ (404,334)
Balance-beginning of period (in shares) at Jan. 31, 2015   38,466,000     13,596,000
Consolidated Statements of Stockholders' Investment [Roll Forward]          
Net income 70,528 $ 0 0 70,528 $ 0
Issuance of shares through the Company's equity plans 1,754 $ 1 1,753 0 0
Issuance of shares through the Company's equity plans, including tax benefit (in shares)   162,000      
Adjustment to income tax benefit from exercises of employee stock options (83) $ 0 (83) 0 0
Purchase of shares under the stock repurchase program (89,212)       $ (89,212)
Purchase of shares under the stock repurchase program (in shares)         2,193,000
Settlement of net share equity awards (in shares)         43,000
Cash used to settle net share equity awards (2,120)       $ (2,120)
Stock-based compensation 5,198 0 5,198 0 0
Balance-end of period at Jan. 30, 2016 310,846 $ 386 169,543 636,583 $ (495,666)
Balance-end of period (in shares) at Jan. 30, 2016   38,628,000     15,832,000
Consolidated Statements of Stockholders' Investment [Roll Forward]          
Net income 61,075 $ 0 0 61,075 $ 0
Issuance of shares through the Company's equity plans 961 $ 1 960 0 0
Issuance of shares through the Company's equity plans, including tax benefit (in shares)   111,000      
Adjustment to income tax benefit from exercises of employee stock options (376) $ 0 (376) 0 0
Purchase of shares under the stock repurchase program (42,115)       $ (42,115)
Purchase of shares under the stock repurchase program (in shares)         1,209,000
Settlement of net share equity awards (in shares)         26,000
Cash used to settle net share equity awards (943)       $ (943)
Stock-based compensation 4,592 0 4,592 0 0
Balance-end of period at Jan. 28, 2017 $ 334,040 $ 387 174,719 697,658 $ (538,724)
Balance-end of period (in shares) at Jan. 28, 2017 38,739,079 38,739,000     17,067,000
Consolidated Statements of Stockholders' Investment [Roll Forward]          
Net income $ 35,030 $ 0 0 35,030 $ 0
Issuance of shares through the Company's equity plans 667 $ 2 665 0 0
Issuance of shares through the Company's equity plans, including tax benefit (in shares)   124,000      
Adjustment for adoption of accounting standard 485 $ 0 1,272 (787) 0
Purchase of shares under the stock repurchase program (53,794)       $ (53,794)
Purchase of shares under the stock repurchase program (in shares)         2,818,000
Settlement of net share equity awards (in shares)         25,000
Cash used to settle net share equity awards (712)       $ (712)
Stock-based compensation 3,880 0 3,880 0 0
Balance-end of period at Feb. 03, 2018 $ 319,596 $ 389 $ 180,536 $ 731,901 $ (593,230)
Balance-end of period (in shares) at Feb. 03, 2018 38,862,929 38,863,000     19,910,000